Ann Leland, PharmD

Sr Dir Clinical Program Development
Prime Therapeutics, LLC

Poster(s):

• (14) Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program
  Wednesday, October 29, 2025